Stephen G. Dilly - 21 Feb 2023 Form 4 Insider Report for CODEXIS, INC. (CDXS)

Role
President and Chief Executive Officer, Director
Signature
/s/ Sriram Ryali, Attorney-in-Fact for Stephen G. Dilly
Issuer symbol
CDXS
Transactions as of
21 Feb 2023
Transactions value $
$0
Form type
4
Date filed
21 Feb 2023, 19:26
Previous filing
09 Mar 2023
Next filing
12 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDXS Common Stock Award $0 +113K +331.14% $0.00 146K 21 Feb 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDXS Stock Option (Right to Buy) Award $0 +338K $0.00 338K 21 Feb 2023 Common Stock 338K $5.44 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted Stock Units ("RSUs") vest 1/3 annually from February 21, 2023 such that the RSUs will be fully vested on February 21, 2026. Each RSU represents a contingent right to receive one share of Codexis common stock.
F2 Option vests and becomes exercisable with respect to 25% of the shares subject thereto on February 21, 2024, with 1/48th of the shares vesting monthly thereafter, such that the option will be fully vested and exercisable on February 21, 2027, in each case, subject to continued service through the applicable vesting date.

Remarks:

President and Chief Executive Officer